Brief: Cytokinetics Inc Prices Its Offering Of $650.0 Million Aggregate Principal Amount Of 1.75% Convertible Senior Notes Due 2031

Cytokinetics, Incorporated

17/09/2025 04:48

Sept 16 (Reuters) - Cytokinetics Inc CYTK.O:

CYTOKINETICS ANNOUNCES PRICING OF UPSIZED $650.0 MILLION CONVERTIBLE SENIOR NOTES OFFERING; REFINANCES A PORTION OF 2027 CONVERTIBLE NOTES

CYTOKINETICS INC - PRICES $650 MILLION CONVERTIBLE NOTES DUE 2031

CYTOKINETICS INC  - PRICING OF ITS OFFERING OF $650.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 1.75% CONVERTIBLE SENIOR NOTES DUE 2031

Source text: ID:nGNX7tGD0Y

Further company coverage: CYTK.O

 ((Reuters.briefs@thomsonreuters.com;))